COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics | Common Shares | 00461U105 | 22,353 | 1,539,480 | SH | | SOLE | | 1,539,480 | 0 | 0 |
Amarin | Ordinary Shares | 023111206 | 0 | 1 | SH | | SOLE | | 1 | 0 | 0 |
Amarin | Common Shares - ADR | 023111206 | 84,739 | 5,208,305 | SH | | SOLE | | 5,208,305 | 0 | 0 |
Apellis Pharmaceuticals, Inc | Common Shares | 03753U106 | 9,772 | 549,580 | SH | | SOLE | | 549,580 | 0 | 0 |
Ascendis Pharma A/S | Ordinary Shares | 04351P101 | 104,942 | 1,480,976 | SH | | SOLE | | 1,480,976 | 0 | 0 |
Ascendis Pharma A/S | Common Shares - ADR | 04351P101 | 70,756 | 998,538 | SH | | SOLE | | 998,538 | 0 | 0 |
Audentes Therapeutics | Common Shares | 05070R104 | 36,963 | 933,640 | SH | | SOLE | | 933,640 | 0 | 0 |
Auris Medical Holding AG | Warrant(s) | H0381L104 | 0 | 140,000 | SH | | SOLE | | 140,000 | 0 | 0 |
Chiasma | Common Shares | 16706W102 | 5,869 | 1,630,221 | SH | | SOLE | | 1,630,221 | 0 | 0 |
Chiasma | Warrant(s) | 16706W102 | 0 | 136,881 | SH | | SOLE | | 136,881 | 0 | 0 |
Coherus BioSciences | Common Shares | 19249H103 | 47,326 | 2,868,221 | SH | | SOLE | | 2,868,221 | 0 | 0 |
Edge Therapeutics | Common Shares | 279870109 | 2,339 | 2,852,711 | SH | | SOLE | | 2,852,711 | 0 | 0 |
Entasis Therapeutics Holdings Inc. | Common Shares | 293614103 | 12,840 | 1,180,178 | SH | | SOLE | | 1,180,178 | 0 | 0 |
Histogenics | Common Shares | 43358V109 | 1,132 | 2,077,040 | SH | | SOLE | | 2,077,040 | 0 | 0 |
Iterum Therapeutics | Common Shares | G6333L101 | 11,438 | 1,726,514 | SH | | SOLE | | 1,726,514 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd | Common Shares - Class A | G5269C101 | 23,529 | 922,700 | SH | | SOLE | | 922,700 | 0 | 0 |
Merus N.V. | Common Shares | N5749R100 | 38,711 | 1,961,039 | SH | | SOLE | | 1,961,039 | 0 | 0 |
Natera | Common Shares | 632307104 | 74,227 | 3,100,560 | SH | | SOLE | | 3,100,560 | 0 | 0 |
Nucana Biomed | Ordinary Shares | GB00BYWYV | 99,680 | 4,000,000 | SH | | SOLE | | 4,000,000 | 0 | 0 |
Nucana Biomed | Common Shares - ADR | 67022C106 | 16,613 | 666,666 | SH | | SOLE | | 666,666 | 0 | 0 |
ObsEva SA | Common Shares | H5861P103 | 85,636 | 4,749,623 | SH | | SOLE | | 4,749,623 | 0 | 0 |
Principia Biopharma | Common Shares | 74257L108 | 59,556 | 2,038,208 | SH | | SOLE | | 2,038,208 | 0 | 0 |
Principia Biopharma | Warrant(s) | 74257L108 | 0 | 20,938 | SH | | SOLE | | 20,938 | 0 | 0 |
Spark Therapeutics | Common Shares | 84652J103 | 26,253 | 481,270 | SH | | SOLE | | 481,270 | 0 | 0 |
Synlogic Inc. (fmrly Mirna) | Common Shares | 87166L100 | 8,170 | 574,972 | SH | | SOLE | | 574,972 | 0 | 0 |
Y-mAbs Therapeutics, Inc | Common Shares | 984241109 | 55,890 | 2,104,278 | SH | | SOLE | | 2,104,278 | 0 | 0 |
Adamas Pharmaceuticals Inc | COMM | 00548A106 | 976 | 48,743 | SH | | SOLE | | 48,743 | 0 | 0 |
Adaptimmune Therapeutics PLC | ADR | 00653A107 | 172 | 12,678 | SH | | SOLE | | 12,678 | 0 | 0 |
Aduro Biotech Inc | COMM | 00739L101 | 196 | 26,712 | SH | | SOLE | | 26,712 | 0 | 0 |
Aimmune Therapeutics Inc | COMM | 00900T107 | 853 | 31,263 | SH | | SOLE | | 31,263 | 0 | 0 |
Alexion Pharmaceuticals Inc | COMM | 015351109 | 1,278 | 9,196 | SH | | SOLE | | 9,196 | 0 | 0 |
Allergan plc | COMM | G0177J108 | 2,577 | 13,529 | SH | | SOLE | | 13,529 | 0 | 0 |
Amicus Therapeutics Inc | COMM | 03152W109 | 760 | 62,834 | SH | | SOLE | | 62,834 | 0 | 0 |
AnaptysBio Inc | COMM | 032724106 | 979 | 9,808 | SH | | SOLE | | 9,808 | 0 | 0 |
ArQule Inc | COMM | 04269E107 | 304 | 53,734 | SH | | SOLE | | 53,734 | 0 | 0 |
AstraZeneca PLC | ADR | 046353108 | 1,344 | 33,965 | SH | | SOLE | | 33,965 | 0 | 0 |
AstraZeneca PLC | COMM | 046353108 | 1,080 | 27,300 | SH | Call | SOLE | | 27,300 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd | COMM | G11196105 | 705 | 18,784 | SH | | SOLE | | 18,784 | 0 | 0 |
Blueprint Medicines Corp | COMM | 09627Y109 | 565 | 7,240 | SH | | SOLE | | 7,240 | 0 | 0 |
Catalyst Pharmaceuticals Inc | COMM | 14888U101 | 675 | 178,518 | SH | | SOLE | | 178,518 | 0 | 0 |
Clearside Biomedical Inc | COMM | 185063104 | 526 | 85,510 | SH | | SOLE | | 85,510 | 0 | 0 |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 441 | 76,034 | SH | | SOLE | | 76,034 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 761 | 69,798 | SH | | SOLE | | 69,798 | 0 | 0 |
Epizyme Inc | COMM | 29428V104 | 435 | 41,084 | SH | | SOLE | | 41,084 | 0 | 0 |
Esperion Therapeutics Inc | COMM | 29664W105 | 229 | 5,165 | SH | | SOLE | | 5,165 | 0 | 0 |
Exelixis Inc | COMM | 30161Q104 | 1,009 | 56,960 | SH | | SOLE | | 56,960 | 0 | 0 |
Fate Therapeutics Inc | COMM | 31189P102 | 241 | 14,800 | SH | | SOLE | | 14,800 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 540 | 94,204 | SH | | SOLE | | 94,204 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 1,318 | 41,646 | SH | | SOLE | | 41,646 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 639 | 191,168 | SH | | SOLE | | 191,168 | 0 | 0 |
Kadmon Holdings Inc | Warrant | 48283N106 | 0 | 59,909 | SH | | SOLE | | 59,909 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 133 | 13,472 | SH | | SOLE | | 13,472 | 0 | 0 |
Kura Oncology Inc | COMM | 50127T109 | 605 | 34,568 | SH | | SOLE | | 34,568 | 0 | 0 |
Molecular Partners AG | COMM | H55351102 | 652 | 29,092 | SH | | SOLE | | 29,092 | 0 | 0 |
MorphoSys AG | COMM | D55040105 | 452 | 4,227 | SH | | SOLE | | 4,227 | 0 | 0 |
OncoMed Pharmaceuticals Inc | COMM | 68234X102 | 146 | 68,899 | SH | | SOLE | | 68,899 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 296 | 107,674 | SH | | SOLE | | 107,674 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 2,176 | 47,458 | SH | | SOLE | | 47,458 | 0 | 0 |
Rhythm Pharmaceuticals Inc | COMM | 76243J105 | 646 | 22,162 | SH | | SOLE | | 22,162 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 1,475 | 459,442 | SH | | SOLE | | 459,442 | 0 | 0 |
Sanofi SA | ADR | 80105N105 | 2,598 | 58,153 | SH | | SOLE | | 58,153 | 0 | 0 |
Sarepta Therapeutics Inc | COMM | 803607100 | 682 | 4,221 | SH | | SOLE | | 4,221 | 0 | 0 |
Savara Inc | COMM | 805111101 | 1,084 | 97,138 | SH | | SOLE | | 97,138 | 0 | 0 |
Spring Bank Pharmaceuticals Inc | COMM | 849431101 | 325 | 26,954 | SH | | SOLE | | 26,954 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 197 | 24,405 | SH | | SOLE | | 24,405 | 0 | 0 |
TESARO Inc | COMM | 881569107 | 1,230 | 31,533 | SH | | SOLE | | 31,533 | 0 | 0 |
Adamas Pharmaceuticals Inc | COMM | 00548A106 | 3,888 | 194,205 | SH | | OTR | 2 | 194,205 | 0 | 0 |
Adaptimmune Therapeutics PLC | ADR | 00653A107 | 685 | 50,488 | SH | | OTR | 2 | 50,488 | 0 | 0 |
Aduro Biotech Inc | COMM | 00739L101 | 783 | 106,483 | SH | | OTR | 2 | 106,483 | 0 | 0 |
Aimmune Therapeutics Inc | COMM | 00900T107 | 3,425 | 125,554 | SH | | OTR | 2 | 125,554 | 0 | 0 |
Alexion Pharmaceuticals Inc | COMM | 015351109 | 5,104 | 36,718 | SH | | OTR | 2 | 36,718 | 0 | 0 |
Allergan plc | COMM | G0177J108 | 10,273 | 53,932 | SH | | OTR | 2 | 53,932 | 0 | 0 |
Amicus Therapeutics Inc | COMM | 03152W109 | 3,028 | 250,487 | SH | | OTR | 2 | 250,487 | 0 | 0 |
AnaptysBio Inc | COMM | 032724106 | 3,901 | 39,101 | SH | | OTR | 2 | 39,101 | 0 | 0 |
ArQule Inc | COMM | 04269E107 | 1,240 | 218,997 | SH | | OTR | 2 | 218,997 | 0 | 0 |
AstraZeneca PLC | ADR | 046353108 | 5,348 | 135,164 | SH | | OTR | 2 | 135,164 | 0 | 0 |
AstraZeneca PLC | COMM | 046353108 | 4,297 | 108,600 | SH | Call | OTR | 2 | 108,600 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd | COMM | G11196105 | 2,807 | 74,751 | SH | | OTR | 2 | 74,751 | 0 | 0 |
Blueprint Medicines Corp | COMM | 09627Y109 | 2,251 | 28,831 | SH | | OTR | 2 | 28,831 | 0 | 0 |
Catalyst Pharmaceuticals Inc | COMM | 14888U101 | 3,337 | 882,791 | SH | | OTR | 2 | 882,791 | 0 | 0 |
Clearside Biomedical Inc | COMM | 185063104 | 2,096 | 340,885 | SH | | OTR | 2 | 340,885 | 0 | 0 |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 1,756 | 302,678 | SH | | OTR | 2 | 302,678 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 3,032 | 278,167 | SH | | OTR | 2 | 278,167 | 0 | 0 |
Epizyme Inc | COMM | 29428V104 | 1,734 | 163,615 | SH | | OTR | 2 | 163,615 | 0 | 0 |
Esperion Therapeutics Inc | COMM | 29664W105 | 912 | 20,547 | SH | | OTR | 2 | 20,547 | 0 | 0 |
Exelixis Inc | COMM | 30161Q104 | 4,017 | 226,685 | SH | | OTR | 2 | 226,685 | 0 | 0 |
Fate Therapeutics Inc | COMM | 31189P102 | 960 | 58,907 | SH | | OTR | 2 | 58,907 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 2,152 | 375,543 | SH | | OTR | 2 | 375,543 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 5,255 | 166,024 | SH | | OTR | 2 | 166,024 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 3,199 | 957,858 | SH | | OTR | 2 | 957,858 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 537 | 54,373 | SH | | OTR | 2 | 54,373 | 0 | 0 |
Kura Oncology Inc | COMM | 50127T109 | 2,446 | 139,775 | SH | | OTR | 2 | 139,775 | 0 | 0 |
Molecular Partners AG | COMM | H55351102 | 2,596 | 115,868 | SH | | OTR | 2 | 115,868 | 0 | 0 |
MorphoSys AG | COMM | D55040105 | 1,802 | 16,850 | SH | | OTR | 2 | 16,850 | 0 | 0 |
OncoMed Pharmaceuticals Inc | COMM | 68234X102 | 251 | 118,257 | SH | | OTR | 2 | 118,257 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 1,602 | 582,545 | SH | | OTR | 2 | 582,545 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 8,674 | 189,190 | SH | | OTR | 2 | 189,190 | 0 | 0 |
Rhythm Pharmaceuticals Inc | COMM | 76243J105 | 2,634 | 90,312 | SH | | OTR | 2 | 90,312 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 5,879 | 1,831,567 | SH | | OTR | 2 | 1,831,567 | 0 | 0 |
Sanofi SA | ADR | 80105N105 | 10,356 | 231,827 | SH | | OTR | 2 | 231,827 | 0 | 0 |
Sarepta Therapeutics Inc | COMM | 803607100 | 2,714 | 16,801 | SH | | OTR | 2 | 16,801 | 0 | 0 |
Savara Inc | COMM | 805111101 | 4,418 | 395,834 | SH | | OTR | 2 | 395,834 | 0 | 0 |
Spring Bank Pharmaceuticals Inc | COMM | 849431101 | 1,294 | 107,422 | SH | | OTR | 2 | 107,422 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 785 | 97,183 | SH | | OTR | 2 | 97,183 | 0 | 0 |
TESARO Inc | COMM | 881569107 | 4,901 | 125,637 | SH | | OTR | 2 | 125,637 | 0 | 0 |
Adamas Pharmaceuticals Inc | COMM | 00548A106 | 2,058 | 102,808 | SH | | OTR | 1 | 102,808 | 0 | 0 |
Adaptimmune Therapeutics PLC | ADR | 00653A107 | 363 | 26,753 | SH | | OTR | 1 | 26,753 | 0 | 0 |
Aduro Biotech Inc | COMM | 00739L101 | 414 | 56,384 | SH | | OTR | 1 | 56,384 | 0 | 0 |
Aimmune Therapeutics Inc | COMM | 00900T107 | 1,786 | 65,478 | SH | | OTR | 1 | 65,478 | 0 | 0 |
Alexion Pharmaceuticals Inc | COMM | 015351109 | 2,703 | 19,446 | SH | | OTR | 1 | 19,446 | 0 | 0 |
Allergan plc | COMM | G0177J108 | 5,440 | 28,560 | SH | | OTR | 1 | 28,560 | 0 | 0 |
Amicus Therapeutics Inc | COMM | 03152W109 | 1,604 | 132,648 | SH | | OTR | 1 | 132,648 | 0 | 0 |
AnaptysBio Inc | COMM | 032724106 | 2,066 | 20,706 | SH | | OTR | 1 | 20,706 | 0 | 0 |
ArQule Inc | COMM | 04269E107 | 643 | 113,540 | SH | | OTR | 1 | 113,540 | 0 | 0 |
AstraZeneca PLC | ADR | 046353108 | 2,828 | 71,479 | SH | | OTR | 1 | 71,479 | 0 | 0 |
AstraZeneca PLC | COMM | 046353108 | 2,275 | 57,500 | SH | Call | OTR | 1 | 57,500 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd | COMM | G11196105 | 1,484 | 39,531 | SH | | OTR | 1 | 39,531 | 0 | 0 |
Blueprint Medicines Corp | COMM | 09627Y109 | 1,192 | 15,268 | SH | | OTR | 1 | 15,268 | 0 | 0 |
Catalyst Pharmaceuticals Inc | COMM | 14888U101 | 1,846 | 488,243 | SH | | OTR | 1 | 488,243 | 0 | 0 |
Clearside Biomedical Inc | COMM | 185063104 | 1,110 | 180,519 | SH | | OTR | 1 | 180,519 | 0 | 0 |
Conatus Pharmaceuticals Inc | COMM | 20600T108 | 929 | 160,203 | SH | | OTR | 1 | 160,203 | 0 | 0 |
Dermira Inc | COMM | 24983L104 | 1,606 | 147,328 | SH | | OTR | 1 | 147,328 | 0 | 0 |
Epizyme Inc | COMM | 29428V104 | 918 | 86,619 | SH | | OTR | 1 | 86,619 | 0 | 0 |
Esperion Therapeutics Inc | COMM | 29664W105 | 483 | 10,887 | SH | | OTR | 1 | 10,887 | 0 | 0 |
Exelixis Inc | COMM | 30161Q104 | 2,125 | 119,949 | SH | | OTR | 1 | 119,949 | 0 | 0 |
Fate Therapeutics Inc | COMM | 31189P102 | 508 | 31,184 | SH | | OTR | 1 | 31,184 | 0 | 0 |
Foamix Pharmaceuticals Ltd | COMM | M46135105 | 1,140 | 198,872 | SH | | OTR | 1 | 198,872 | 0 | 0 |
Heron Therapeutics Inc | COMM | 427746102 | 2,783 | 87,919 | SH | | OTR | 1 | 87,919 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 1,314 | 393,476 | SH | | OTR | 1 | 393,476 | 0 | 0 |
Kadmon Holdings Inc | Warrant | 48283N106 | 0 | 240,091 | SH | | OTR | 1 | 240,091 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 274 | 27,810 | SH | | OTR | 1 | 27,810 | 0 | 0 |
Kura Oncology Inc | COMM | 50127T109 | 1,278 | 73,042 | SH | | OTR | 1 | 73,042 | 0 | 0 |
MorphoSys AG | COMM | D55040105 | 954 | 8,923 | SH | | OTR | 1 | 8,923 | 0 | 0 |
OncoMed Pharmaceuticals Inc | COMM | 68234X102 | 442 | 208,588 | SH | | OTR | 1 | 208,588 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 818 | 297,559 | SH | | OTR | 1 | 297,559 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 4,594 | 100,187 | SH | | OTR | 1 | 100,187 | 0 | 0 |
Rhythm Pharmaceuticals Inc | COMM | 76243J105 | 1,366 | 46,828 | SH | | OTR | 1 | 46,828 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 3,113 | 969,922 | SH | | OTR | 1 | 969,922 | 0 | 0 |
Sanofi SA | ADR | 80105N105 | 5,484 | 122,766 | SH | | OTR | 1 | 122,766 | 0 | 0 |
Sarepta Therapeutics Inc | COMM | 803607100 | 1,436 | 8,893 | SH | | OTR | 1 | 8,893 | 0 | 0 |
Savara Inc | COMM | 805111101 | 2,291 | 205,253 | SH | | OTR | 1 | 205,253 | 0 | 0 |
Spring Bank Pharmaceuticals Inc | COMM | 849431101 | 666 | 55,270 | SH | | OTR | 1 | 55,270 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 416 | 51,524 | SH | | OTR | 1 | 51,524 | 0 | 0 |
TESARO Inc | COMM | 881569107 | 2,594 | 66,505 | SH | | OTR | 1 | 66,505 | 0 | 0 |